South Korean scientists have developed a method using mussel adhesive protein to connect severed nerve ends without the need to use suture threads.
A joint research team from Pohang University of Science and Technology, Ewha Woman's University, and the Catholic University of Korea Seoul St. Mary’s Hospital announced that it had developed a hydrogel adhesive for medical use based on mussel adhesive protein.
Nerves are one of the more difficult tissues to replicate. As a result, when they are cut, the only option to rejoin them is to carefully sew them together with suture threads.
This approach, however, necessitates a high level of medical expertise and takes a long time. Furthermore, there is a possibility that the secondary injury induced by suture thread penetration will impede nerve cell proliferation.
The researchers aimed to address these issues by transforming mussel adhesive protein into a jelly-like photo-crosslinking hydrogel adhesive.
The protein secreted by mussels to adhere to the moist surfaces of solid rocks is known as mussel adhesive protein.
When not exposed to light, this adhesive lives as a liquid. When exposed to visible light, it rapidly transforms into a hydrogel with sticky properties.
The use of this glue to connect severed nerve segments helps to avoid further injury and minimize immunological inflammation.


Supreme Court Asked to Reinstate Mail-Order Access to Abortion Pill Mifepristone
GSK Reportedly Nears $9 Billion Acquisition of Cancer Drug Developer Nuvalent
Trump Signs Executive Order to Boost AI Research in Childhood Cancer
Bank Regulation Rollbacks in the U.S. and UK Could Increase Financial Risks, Study Warns
NASA's Artemis II Mission: First Crewed Lunar Journey Since Apollo
Gold Price Ends Lower for Fourth Week Despite Rebound as Fed Rate Hike Bets Strengthen
Why the future of marijuana legalization remains hazy despite high public support
Oil Prices Drop as Middle East Supply Recovery Eases Market Concerns
Asian Currencies Trade Mixed as Yen Hovers Near 40-Year Low, Dollar Holds Firm on Fed Outlook
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026
Trump Reportedly Approves Plan to Remove FDA Commissioner Marty Makary Amid Growing Controversies
Tabletop particle accelerator could transform medicine and materials science
Oil Prices Drop as Strait of Hormuz Shipping Recovers
South Korea’s KOSPI Jumps Over 5% as Samsung, SK Hynix Rally on Micron Earnings Boost
Wall Street Ends Lower as AI Stocks Drag Markets, Fed Rate Outlook Shifts 



